San Diego, CA, United States of America

Zhe Li

USPTO Granted Patents = 54 

 

 

Average Co-Inventor Count = 3.4

ph-index = 18

Forward Citations = 1,146(Granted Patents)

Forward Citations (Not Self Cited) = 937(Oct 12, 2025)


Inventors with similar research interests:


Location History:

  • South San Francisco, CA (US) (2015 - 2019)
  • San Diego, CA (US) (2002 - 2023)

Company Filing History:


Years Active: 2002-2025

Loading Chart...
Loading Chart...
Loading Chart...
54 patents (USPTO):

Title: The Innovative Journey of Zhe Li: A Prominent Inventor in Iron Metabolism Research

Introduction

Zhe Li, based in San Diego, California, is a distinguished inventor known for his contributions to the field of pharmaceuticals. With an impressive portfolio of 54 patents, Li's work has made significant impacts, particularly in the understanding and treatment of iron metabolism disorders. His innovative approach combines chemistry and medicine, paving the way for new therapeutic solutions.

Latest Patents

Among Zhe Li's recent inventions are the patents on cycloalkyl pyrimidines as ferroportin inhibitors. These compounds, formulated under specific chemical structures, serve as important pharmaceutical agents aimed at addressing diseases that arise from a deficiency of hepcidin or disorders related to iron metabolism. Conditions such as thalassemia, sickle cell disease, hemochromatosis, and kidney injuries stand to benefit from the methodologies and compositions developed through Li's research.

Career Highlights

Zhe Li has had a notable career in the pharmaceutical industry, having worked with companies such as Global Blood Therapeutics, Inc. and Sgx Pharmaceuticals, Inc. His tenure at these organizations has allowed him to advance his research and translate innovative ideas into practical medical solutions.

Collaborations

Throughout his career, Zhe Li has collaborated with esteemed colleagues in the field, including Qing Xu and Brian Walter Metcalf. These partnerships have fostered a rich environment for creativity and scientific inquiry, leading to groundbreaking advancements in the treatment of iron-related diseases.

Conclusion

In summary, Zhe Li's work stands as a testament to the power of innovation in medicine. His extensive patent portfolio, particularly in the area of ferroportin inhibitors, highlights his commitment to addressing critical health issues. As research in iron metabolism continues to evolve, Zhe Li remains at the forefront, contributing valuable insights and solutions for the medical community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…